Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine C Coombs

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Cancers|March 29, 2023
Cellular Therapies in Chronic Lymphocytic Leukemia and Richter's Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell TransplantCatherine C Coombs, Saumya Easaw, Natalie S Grover, et al.
Obstetrics and Gynecology|February 9, 2018
Maternal Malignancy Evaluation After Discordant Cell-Free DNA ResultsLaura M Carlson, Emily Hardisty, Catherine C Coombs, et al.
Seminars in Oncology Nursing|November 25, 2019
Advances in Genomic Profiling and Risk Stratification in Acute Myeloid LeukemiaDaniel R Richardson, Matthew C Foster, Catherine C Coombs, et al.
Blood Reviews|June 26, 2022
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myelomaJeremy Meier, Jeffrey L Jensen, Christopher Dittus, et al.
Leukemia & Lymphoma|June 1, 2012
Chronic lymphocytic leukemia in African AmericansCatherine C Coombs, Lorenzo Falchi, J Brice Weinberg, et al.
Therapeutic Advances in Hematology|June 24, 2022
The potential of pirtobrutinib in multiple B-cell malignanciesJeffrey L Jensen, Anthony R Mato, Camila Pena, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 4, 2016
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic CriteriaCatherine C Coombs, Lisa M DeAngelis, James H Feusner, et al.
Future Oncology (London, England)|October 3, 2025
Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphomaSyed Ibrahim, Nghia Pham, Aarushi Sahni, et al.
Leukemia & Lymphoma|March 9, 2022
Evaluation of an interdisciplinary venetoclax initiation process in minimizing risk of tumor lysis syndromeMonica Cozad, Sarah E Stump, Kaitlyn Buhlinger, et al.
Clinical Case Reports|December 3, 2019
Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosisChristopher Trennepohl, Jonathan Sorah, Patrick Eulitt, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Cancers|March 29, 2023
Cellular Therapies in Chronic Lymphocytic Leukemia and Richter's Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell TransplantCatherine C Coombs, Saumya Easaw, Natalie S Grover, et al.
Obstetrics and Gynecology|February 9, 2018
Maternal Malignancy Evaluation After Discordant Cell-Free DNA ResultsLaura M Carlson, Emily Hardisty, Catherine C Coombs, et al.
Seminars in Oncology Nursing|November 25, 2019
Advances in Genomic Profiling and Risk Stratification in Acute Myeloid LeukemiaDaniel R Richardson, Matthew C Foster, Catherine C Coombs, et al.
Blood Reviews|June 26, 2022
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myelomaJeremy Meier, Jeffrey L Jensen, Christopher Dittus, et al.
Leukemia & Lymphoma|June 1, 2012
Chronic lymphocytic leukemia in African AmericansCatherine C Coombs, Lorenzo Falchi, J Brice Weinberg, et al.
Therapeutic Advances in Hematology|June 24, 2022
The potential of pirtobrutinib in multiple B-cell malignanciesJeffrey L Jensen, Anthony R Mato, Camila Pena, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 4, 2016
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic CriteriaCatherine C Coombs, Lisa M DeAngelis, James H Feusner, et al.
Future Oncology (London, England)|October 3, 2025
Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphomaSyed Ibrahim, Nghia Pham, Aarushi Sahni, et al.
Leukemia & Lymphoma|March 9, 2022
Evaluation of an interdisciplinary venetoclax initiation process in minimizing risk of tumor lysis syndromeMonica Cozad, Sarah E Stump, Kaitlyn Buhlinger, et al.
Clinical Case Reports|December 3, 2019
Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosisChristopher Trennepohl, Jonathan Sorah, Patrick Eulitt, et al.
Pageof 9